Search

everythinglearnresearchcommunity

for

Search:↓

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

MITF and WNT3A are key in Dun Mongolian horse pigmentation.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

TPA is about 50 times more effective at promoting tumors than MZ.

A new method accurately measures a drug in skin for cancer therapy research.

Cedrol may be an effective treatment for colorectal cancer.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

Red laser therapy helped regrow hair in an alopecia areata patient within 21 days.

CG2001 is safe and well-tolerated for treating hair loss in men.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

A specific type II hair keratin was identified and found in hair cortex and tongue cells.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

The document does not provide information about hair loss treatment.

TEDAR is crucial for skin cell differentiation and barrier formation.

Basal cell carcinomas may differentiate similarly to hair follicles and could be influenced by hair cycle-related treatments.

Raman micro-spectroscopy can help distinguish basal cell carcinoma from hair follicles in skin tissue.

Biotin helps maintain hair follicle growth by affecting cell death and survival signals.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

A new compound shows promise as a topical treatment for hair loss.

A low-cost, 3D-printed light therapy device is safe and effective but needs more testing before use on people.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.